User profiles for "author:Avi Caspi"
Avi CaspiJerusalem College of Technology Verified email at jct.ac.il Cited by 2666 |
Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the …
M Packer, JJV McMurray, H Krum, W Kiowski… - JACC: Heart Failure, 2017 - jacc.org
Objectives: The objective of this clinical trial was to evaluate the long-term effect of
endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with …
endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with …
Enhanced diffusion in active intracellular transport
We show that within a living eukaryotic cell, mean square displacement of an engulfed
microsphere shows enhanced diffusion scaling as t 3/2 at short times, with a clear crossover …
microsphere shows enhanced diffusion scaling as t 3/2 at short times, with a clear crossover …
Diffusion and directed motion in cellular transport
We study the motion of a probe driven by microtubule-associated motors within a living
eukaryotic cell. The measured mean square displacement,< x (t) 2> of engulfed 2 and 3 μ m …
eukaryotic cell. The measured mean square displacement,< x (t) 2> of engulfed 2 and 3 μ m …
The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis
Objective To investigate the ability of 28 blind subjects implanted with a 60-electrode Argus
II (Second Sight Medical Products Inc) retinal prosthesis system to detect the direction of a …
II (Second Sight Medical Products Inc) retinal prosthesis system to detect the direction of a …
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we …
Background Cerebrovascular accidents (CVAs), transient ischemic attacks (TIAs), and
peripheral arterial disease (PAD) frequently coexist with coronary artery disease (CAD) and …
peripheral arterial disease (PAD) frequently coexist with coronary artery disease (CAD) and …
Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant
A Caspi, JD Dorn, KH McClure… - Archives of …, 2009 - jamanetwork.com
Objective To demonstrate that an epiretinal prosthesis can produce patterned visual
perception in patients blinded by photoreceptor degeneration who have no other treatment …
perception in patients blinded by photoreceptor degeneration who have no other treatment …
The time course of visual information accrual guiding eye movement decisions
A Caspi, BR Beutter… - Proceedings of the …, 2004 - National Acad Sciences
Saccadic eye movements are the result of neural decisions about where to move the eyes.
These decisions are based on visual information accumulated before the saccade; however …
These decisions are based on visual information accumulated before the saccade; however …
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure
A Barsheshet, M Garty, E Grossman… - Archives of Internal …, 2006 - jamanetwork.com
Background The significance of admission blood glucose level in nondiabetic patients with
heart failure (HF) is unknown. We examined the possible association between admission …
heart failure (HF) is unknown. We examined the possible association between admission …
Preliminary 6 month results from the argustm ii epiretinal prosthesis feasibility study
MS Humayun, JD Dorn, AK Ahuja… - … Conference of the …, 2009 - ieeexplore.ieee.org
The Argustrade II 60 channel epiretinal prosthesis has been developed in order to provide
partial restoration of vision to subjects blinded from outer retinal degenerative disease. To …
partial restoration of vision to subjects blinded from outer retinal degenerative disease. To …
RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo …
E Kaluski, I Kobrin, R Zimlichman, A Marmor… - Journal of the American …, 2003 - jacc.org
Objectives: The objective of this study was to evaluate the addition of intravenous (IV)
tezosentan to standard therapy for patients with pulmonary edema. Background: Tezosentan …
tezosentan to standard therapy for patients with pulmonary edema. Background: Tezosentan …